NET Cancer Day
Nov 15 2012
The inaugural meeting of the Irish Neuroendocrine Neoplasm Group was held this month at Trinity College Dublin. Irish and international experts in carcinoid/NETs gathered to discuss advances in the field, diagnostic and therapeutic practices currently available in Ireland, as well as areas where Ireland is falling behind, especially in specialized nuclear medicine diagnostic and therapy tools.
Dr. Dermot O’Toole, Consultant Gastroenterologist/Pancreatologist and Associate Professor at St. James’s Hospital and Trinity College Dublin, who organized and served as Co-Chair of the Scientific Committee for the meeting, commented that the meeting “formed the backbone in paving the way for developing a recognized Irish Network to provide care for patients with this disease.”
An open patients’ forum on NETs was held in Trinity Biomedical Sciences Institute in conjunction with Worldwide NET Cancer Awareness Day on November 10. Dr. Susan O’Reilly, Director of the National Cancer Control Programme (NCCP), opened the forum and patients and Irish and Swedish NET cancer experts participated in a question and answer session. The creation of a formal Irish Neuroendocrine Patients Group was also an outcome of the day. Read more
Pictured above, left to right: Dr Dermot O’Toole, Consultant Gastroenterologist/Pancreatologist & Associate Professor St James’s Hospital & Trinity College Dublin; Dr Derek Power, Consultant Medical Oncologist, Mercy University Hospital, Cork; Ms Barbro Eriksson, Medical Oncologist, University Hospital, Uppsala, Sweden; Dr Susan O’Reilly, Director of National Cancer Control Programme; Mr Dan Granberg, Lead Uppsala NET Centre of Excellence, University Hospital, Uppsala and Justin Groghegan, Consultant Hepato-Bilairy Pancreatic
Fennell Photography Copyright 2012.